We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Owlstone Medical Receives CE Mark Approval for ReCIVA™

News   Oct 05, 2016

 
Owlstone Medical Receives CE Mark Approval for ReCIVA™
 
 
Advertisement
 

RELATED ARTICLES

Blood-Based Test Accurately Identifies Viral Infection Before Symptoms Develop

News

A team of Duke Health scientists have identified biomarkers that accurately identify numerous viral infections across the clinical stages of disease, advancing a potential new way to guide treatment, quarantine decisions, and other clinical and public health interventions in the setting of endemic and pandemic infectious diseases.

READ MORE

Why Do Some People With COVID-19 Develop Severe Disease?

News

New findings by scientists at the National Institutes of Health and their collaborators help explain why some people with COVID-19 develop severe disease. The findings also may provide the first molecular explanation for why more men than women die from COVID-19.

READ MORE

AI Algorithm Detects Osteoarthritis Years Before Symptoms Develop

News

Researchers have created a machine-learning algorithm that can detect subtle signs of osteoarthritis, often missed by trained radiologists, on an MRI scan taken years before symptoms even begin.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE